These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 17295660

  • 1. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
    McTaggart SJ, Atkinson K.
    Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
    [Abstract] [Full Text] [Related]

  • 2. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration.
    Kode JA, Mukherjee S, Joglekar MV, Hardikar AA.
    Cytotherapy; 2009 Feb; 11(4):377-91. PubMed ID: 19568970
    [Abstract] [Full Text] [Related]

  • 3. Immunoregulatory function of mesenchymal stem cells.
    Uccelli A, Moretta L, Pistoia V.
    Eur J Immunol; 2006 Oct; 36(10):2566-73. PubMed ID: 17013987
    [Abstract] [Full Text] [Related]

  • 4. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME, Fibbe WE, Rabelink TJ.
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [Abstract] [Full Text] [Related]

  • 5. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
    Arinzeh TL.
    Foot Ankle Clin; 2005 Dec; 10(4):651-65, viii. PubMed ID: 16297825
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R, Tong CK, Seow HF, Vidyadaran S, Dazzi F.
    Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic potential of genetically modified mesenchymal stem cells.
    Kumar S, Chanda D, Ponnazhagan S.
    Gene Ther; 2008 May; 15(10):711-5. PubMed ID: 18356815
    [Abstract] [Full Text] [Related]

  • 9. Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.
    Leal A, Ichim TE, Marleau AM, Lara F, Kaushal S, Riordan NH.
    Cell Immunol; 2008 May; 253(1-2):11-5. PubMed ID: 18627903
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.
    Giordano A, Galderisi U, Marino IR.
    J Cell Physiol; 2007 Apr; 211(1):27-35. PubMed ID: 17226788
    [Abstract] [Full Text] [Related]

  • 12. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J.
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S, Ohnishi S, Yamahara K, Sada M, Harada K, Mishima K, Iwasaki K, Fujiwara M, Kitamura S, Nagaya N, Ikeda T.
    Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
    [Abstract] [Full Text] [Related]

  • 14. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
    Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, Rambaldi A, Remuzzi A, Remuzzi G.
    Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ, McTaggart SJ.
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [Abstract] [Full Text] [Related]

  • 16. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T, Song SU.
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [Abstract] [Full Text] [Related]

  • 17. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury.
    Semedo P, Palasio CG, Oliveira CD, Feitoza CQ, Gonçalves GM, Cenedeze MA, Wang PM, Teixeira VP, Reis MA, Pacheco-Silva A, Câmara NO.
    Int Immunopharmacol; 2009 Jun; 9(6):677-82. PubMed ID: 19146993
    [Abstract] [Full Text] [Related]

  • 18. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury.
    Semedo P, Wang PM, Andreucci TH, Cenedeze MA, Teixeira VP, Reis MA, Pacheco-Silva A, Câmara NO.
    Transplant Proc; 2007 Mar; 39(2):421-3. PubMed ID: 17362746
    [Abstract] [Full Text] [Related]

  • 19. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kawamata M, Kato T, Okochi H, Ochiya T.
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L.
    Transplantation; 2007 Jul 27; 84(2):231-7. PubMed ID: 17667815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.